Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study

Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study

Show other versions (1)

Context. Calcifediol has been proposed as a potential treatment for COVID-19 patients. Objective: To compare the administration or not of oral calcifediol on mortality risk of patients hospitalized because of COVID-19. Design: Retrospective, multicenter, open, non-randomized cohort study. Settings:...

Full description

Bibliographic Details
Main Authors: Alcala-Diaz, Juan F., Limia-Perez, Laura, Gomez-Huelgas, Ricardo, Martin-Escalante, Maria D., Cortes-Rodriguez, Begoña, Zambrana-Garcia, Jose L., Entrenas-Castillo, Marta, Perez-Caballero, Ana I., López-Carmona, Maria D., Garcia-Alegria, Javier, Lozano Rodríguez-Mancheño, Aquiles, Arenas-de Larriva, Maria del Sol, Pérez-Belmonte, Luis M., Jungreis, Irwin, Bouillon, Roger, Quesada-Gomez, Jose Manual, Lopez-Miranda, Jose
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Format: Article
Published: Multidisciplinary Digital Publishing Institute 2022
Online Access:https://hdl.handle.net/1721.1/133188.2

Internet

https://hdl.handle.net/1721.1/133188.2

Similar Items